- Trials with a EudraCT protocol (92)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
92 result(s) found for: Caesarean section.
Displaying page 4 of 5.
EudraCT Number: 2017-001144-36 | Sponsor Protocol Number: CHUBX2015/41 | Start Date*: 2017-11-23 | ||||||||||||||||
Sponsor Name:CHU de Bordeaux | ||||||||||||||||||
Full Title: TRAnexamic Acid for Preventing postpartum hemorrhage following a Cesarean Delivery :a multicenter randomised, double blind placebo controlled trial (TRAAP2) | ||||||||||||||||||
Medical condition: Postpartum hemorrhage, prevention, blood loss, transfusion | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: FR (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-004011-44 | Sponsor Protocol Number: UofATURRIFIC | Start Date*: 2020-05-20 |
Sponsor Name:The University of Adelaide | ||
Full Title: A randomised trial of URsodeoxycholic acid versus RIFampicin in severe early onset Intrahepatic Cholestasis of pregnancy: the TURRIFIC study, comparing their effectiveness in the reduction of pruri... | ||
Medical condition: Intrahepatic Cholestasis of Pregnancy (ICP) is an serious liver condition in pregnancy. The main symptom of this is itching. Ursodeoxycholic acid is routinely used to treat cholestasis but is not... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: FI (Completed) GB (GB - no longer in EU/EEA) SE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2020-003410-12 | Sponsor Protocol Number: RG_19-169 | Start Date*: 2020-12-16 |
Sponsor Name:University of Birmingham | ||
Full Title: Pregnancy ANtihypertensive Drugs: which Agent is best? | ||
Medical condition: Hypertension in pregnancy (chronic hypertension, gestational hypertension or pre-eclampsia) | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2021-004307-40 | Sponsor Protocol Number: ATN-106 | Start Date*: 2022-01-31 | |||||||||||
Sponsor Name:Octapharma AG | |||||||||||||
Full Title: A multicentre, prospective, open-label, uncontrolled Phase 3 study to assess the efficacy, safety and pharmacokinetics of Atenativ in patients with congenital antithrombin deficiency undergoing sur... | |||||||||||||
Medical condition: Congenital antithrombin deficiency | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Trial now transitioned) AT (Trial now transitioned) FR (Trial now transitioned) IT (Trial now transitioned) DE (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-004696-24 | Sponsor Protocol Number: ANESBUPI_1/2014 | Start Date*: 2016-02-29 |
Sponsor Name:HOSPITAL UNIVERSITARIO LA PAZ, SERVICIO DE ANESTESIA | ||
Full Title: Breakthrough pain incidence in pregnant women comparing two Epidural analgesia shemes added to a continuous infusion (bowling planned indicators and analgesia epidural patient controlled): double-b... | ||
Medical condition: EPIDURAL ANALGESIA IN PARTURIENTS | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-000889-35 | Sponsor Protocol Number: CHUB-PIB | Start Date*: 2016-05-26 |
Sponsor Name:Centre Hospitalier Universitaire Brugmann | ||
Full Title: Comparison of two methods of administration of the epidural, by programmed intermittent bolus or continuous perfusion, on the incidence of instrumented deliveries and cesareans in primiparous women. | ||
Medical condition: Fist child delivery with epidural | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-018450-12 | Sponsor Protocol Number: 706079098 | Start Date*: 2010-08-18 | |||||||||||
Sponsor Name:Agneta Blanck Olerup | |||||||||||||
Full Title: Optimising pain control after caesarean section - an evaluation if oxycodone can replace morphine and low potency opioids postoperatively. | |||||||||||||
Medical condition: Pain management after elective cesarean section. | |||||||||||||
|
|||||||||||||
Population Age: Newborns, Under 18, Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-002207-34 | Sponsor Protocol Number: 63569 | Start Date*: 2018-08-29 | |||||||||||
Sponsor Name:Anja Bisgaard Pinborg | |||||||||||||
Full Title: Preparing and timing of the endometrium in modified natural cycle frozen-thawed embryo transfers (mNC-FET) - a randomized controlled multicenter trial | |||||||||||||
Medical condition: Infertility | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001401-16 | Sponsor Protocol Number: 80-83600-98-40001 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Academic Medical Center | |||||||||||||
Full Title: The SUGAR-DIP trial: Oral medication strategy versus insulin for diabetes in pregnancy | |||||||||||||
Medical condition: The medical condition to be investigated in this trial is gestational diabetes with insufficient glycemic control by means of dietary adjustments and thus an indication for addiotional pharmacologi... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000770-29 | Sponsor Protocol Number: Ireland-RctV8 | Start Date*: 2018-06-18 | ||||||||||||||||
Sponsor Name:The Rotunda Hospital | ||||||||||||||||||
Full Title: Investigating the role of early low-dose aspirin in diabetes: A phase III multicentre double-blinded placebo-controlled randomised trial of low-dose aspirin initiated in the first trimester of diab... | ||||||||||||||||||
Medical condition: Pregestational type I or type II diabetes | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Female | |||||||||||||||||
Trial protocol: IE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2016-003181-12 | Sponsor Protocol Number: HOTPOT1 | Start Date*: 2016-10-07 |
Sponsor Name:Royal College of Surgeons in Ireland | ||
Full Title: Can sonographic assessment of pulmonary vascular reactivity following maternal hyperoxygenation therapy predict neonatal outcome in fetuses at risk of pulmonary hypertension? | ||
Medical condition: Persistent pulmonary hypertension of the newborn (PPHN) is a relatively common condition occurring in 7/1000 births and can result in significant cardiovascular instability in the newborn. It occur... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: IE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-005892-83 | Sponsor Protocol Number: WCH/2008/001 | Start Date*: 2009-01-14 |
Sponsor Name:Epsom and St Helier University Hospitals NHS Trust | ||
Full Title: Does metformin improve pregnancy outcomes [ incidence of LGA (≥90% birth weight centile) babies onset of maternal Gestational Diabetes, hypertension, PET, shoulder dystocia, admission to SCBU) in o... | ||
Medical condition: Obesity in pregnancy. Obesity in pregnancy has been identified by Confidential Enquiry into Maternal And Child Health (CEMACH) (2008-2011) as a major health risk to mother and baby. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2014-004249-29 | Sponsor Protocol Number: DALMATION/7212 | Start Date*: 2015-10-30 |
Sponsor Name:The Newcastle Upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: An Open Label, Non-Randomised, Phase II study to Determine if Dabigatran and its Metabolites are Detectable in Breast Milk Following Oral Administration to Non-Breastfeeding Mothers | ||
Medical condition: Future use for VTE prophylaxis. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-000026-30 | Sponsor Protocol Number: ABR35278 | Start Date*: 2013-05-08 | |||||||||||
Sponsor Name:Academic medical centre | |||||||||||||
Full Title: Induction of Labour with a Foley catheter or oral Misoprostol at Term | |||||||||||||
Medical condition: Induction of labour at term | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-000424-25 | Sponsor Protocol Number: 1508175 | Start Date*: 2016-04-12 | |||||||||||||||||||||
Sponsor Name:CHU Saint-Etienne | |||||||||||||||||||||||
Full Title: Low-molecular-weight heparin in constituted vascular intrauterine growth restriction. Randomized multicenter trial | |||||||||||||||||||||||
Medical condition: Intrauterine growth restriction (IUGR) | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||||||||||||
Trial protocol: FR (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002256-25 | Sponsor Protocol Number: HYPATIA | Start Date*: 2018-03-09 | |||||||||||
Sponsor Name:Guy's and St Thomas' NHS Foundation Trust | |||||||||||||
Full Title: HYPATIA: A prospective randomised controlled trial of HYdroxychloroquine to improve Pregnancy outcome in women with AnTIphospholipid Antibodies | |||||||||||||
Medical condition: Pregnant women with antiphospholipid antibodies | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002014-38 | Sponsor Protocol Number: GTC AT HD 012-04 | Start Date*: 2005-10-14 |
Sponsor Name:GTC Biotherapeutics Inc. | ||
Full Title: A Multicenter, Multinational Study to Assess the Safety and Efficacy of Antithrombin alfa in Hereditary Antithrombin (AT) Deficient Patients in High-Risk Situations for Thrombosis | ||
Medical condition: Hereditary Antithrombin Deficient Patients in High risk Situations for Thrombosis. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) DE (Completed) AT (Completed) SE (Completed) DK (Completed) IT (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004478-41 | Sponsor Protocol Number: LCC001 | Start Date*: 2015-03-10 | |||||||||||
Sponsor Name:King's College London [...] | |||||||||||||
Full Title: Phase III trial in IntrahepaTic CHolestasis of pregnancy (ICP) to Evaluate urSodeoxycholic acid (UDCA) in improving perinatal outcomes | |||||||||||||
Medical condition: Intrahepatic Cholestasis of pregnancy | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-004697-25 | Sponsor Protocol Number: V528Nov22 | Start Date*: 2020-09-14 | |||||||||||
Sponsor Name:The Rotunda Hospital | |||||||||||||
Full Title: The Home Induction trial: A randomised open-label trial to assess outpatient induction of labour, and compare efficacy of Propess vs Dilapan-S® for induction of labour at 39 weeks’ gestation in nor... | |||||||||||||
Medical condition: Normal risk nulliparous women who have no pregnancy-related or medical contraindication to Induction of Labour | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: IE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-000620-17 | Sponsor Protocol Number: PPL17 | Start Date*: 2019-05-08 | |||||||||||
Sponsor Name:Dilafor AB | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Proof of Concept Study (section A) with a conditional dose finding follow up (Section B) to Evaluate the Efficacy on Cervical ripening... | |||||||||||||
Medical condition: Induction of labor in pregnant women with unripe cervix | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Female | ||||||||||||
Trial protocol: SE (Completed) FI (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
